首页> 外文期刊>Química Nova >Desenvolvimento e valida??o de metodologia analítica para determina??o de itraconazol em produtos farmacêuticos por CLAE
【24h】

Desenvolvimento e valida??o de metodologia analítica para determina??o de itraconazol em produtos farmacêuticos por CLAE

机译:HPLC测定药品中伊曲康唑的分析方法的开发和验证

获取原文
           

摘要

Itraconazole is a synthetic antifungal drug administered orally with a broad spectrum of activity against mycotic infections. The present work consists of the development and validation of analytical methodology for evaluation of itraconazole in pharmaceutical products by high performance liquid chromatography. The separation was made using the reversed-phase column LC-18, acetonitrile/diethylamine 0.05% v/v, 60:40 v/v, pH 8.0 as mobile phase, methanol as solvent and detection and quantification at 254 nm. The results here obtained show that the analytical methodology is accurate, reproducible, robust and linear over the concentration range 8.0-12.0 μg/mL of itraconazole. The method was applied to pharmaceutical capsules containg itraconazole pellets and showed to be efficient, yielding good results.
机译:伊曲康唑是一种口服的合成抗真菌药物,对真菌感染具有广泛的活性。本工作包括通过高效液相色谱法评估药物中伊曲康唑的分析方法的开发和验证。使用反相柱LC-18、0.05%v / v的乙腈/二乙胺,60:40 v / v,pH 8.0的流动相,甲醇作为溶剂进行分离,并在254 nm处检测和定量。此处获得的结果表明,在伊曲康唑的浓度范围为8.0-12.0μg/ mL的情况下,该分析方法是准确,可重现,耐用且线性的。该方法应用于含有伊曲康唑颗粒的药物胶囊,经证明是有效的,产生了良好的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号